VCYT: Veracyte, Inc.
Performance
VCYT -37.84%
Watchlist
Select an item
Summary
VCYT at a glance
VCYT returned -37.84% over the past year and -12.27% a year over five years. Its worst drop in that year was -60.32%, smaller than 12% of stocks on Redstone, and its Sharpe ratio of -0.12 beats 22% of stocks on Redstone. It pays no dividends.
Current Drawdown
-57.15%
Rolling Volatility
192.79%
Actions
Metrics
Risk Indicators
Alpha-35.85%
Beta2.66x
Sharpe-0.12
Sortino-0.15
Omega0.97
Calmar-0.63
Martin-0.42
Profile
About VCYT
Veracyte Inc is a genomic diagnostics company. The group empowers clinicians with the insights necessary to guide and assure patients at pivotal moments in the race to diagnose and treat cancer.
- Sector
- Health Care
- Industry
- Services: Medical Laboratories
- Market cap
- $2.1B
- Listed
- Oct 2013
- Employees
- 755
- Headquarters
- South San Francisco, CA
- Website
- veracyte.com
Comparisons